Dermatology COVID-19 Registries : Updates and Future Directions - 21/09/21

Doi : 10.1016/j.det.2021.05.013

Esther E. Freeman, MD, PhD ^a,^b,^⁎ , Grace C. Chamberlin, BA ^b, Devon E. McMahon, MD ^a, George J. Hruza, MD, MBA ^c, Dmitri Wall, MB BCh BAO ^d,^e,^f, Nekma Meah, MD, FACD ^g,^h, Rodney Sinclair, MBBS, MD, FACD ⁱ, Esther A. Balogh, MD ^j, Steven R. Feldman, MD, PhD ^j, Michelle A. Lowes, MBBS, PhD ^k, Angelo V. Marzano, MD ^l,^m, Haley B. Naik, MD, MHSc ⁿ, Leslie Castelo-Soccio, MD, PhD ^o, Irene Lara-Corrales, MD, MSc ^p, Kelly M. Cordoro, MD ⁿ, Satveer K. Mahil, MD, PhD ^q, Christopher E.M. Griffiths, MD ^r, Catherine H. Smith, MD ^q, Alan D. Irvine, MD, DSc ^s, Phyllis I. Spuls, MD, PhD ^t, Carsten Flohr, MD, PhD ^u, Lars E. French, MD ^v,^w
^a Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, Boston, MA 02114, USA
^b Medical Practice Evaluation Center, Mongan Institute, Massachusetts General Hospital, Boston, MA, USA
^c Department of Dermatology, Saint Louis University School of Medicine, Saint Louis, MO, USA
^d Hair Restoration Blackrock, Dublin, Ireland
^e National and International Skin Registry Solutions (NISR), Charles Institute of Dermatology, Dublin, Ireland
^f School of Medicine, University College Dublin, Dublin, Ireland
^g St Helens & Knowsley NHS Trust, Marshalls Cross Road, St. Helens WA9 3DA, UK
^h Manchester University, Faculty of Biology, Medicine and Health, Oxford Road, Manchester, UK
ⁱ Sinclair Dermatology, East Melbourne, Victoria 3002, Australia
^j Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston Salem, NC, USA
^k The Rockefeller University, New York, NY, USA
^l Dermatology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
^m Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
ⁿ Department of Dermatology, University of California, San Francisco, CA, USA
^o Section of Pediatric Dermatology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
^p Section of Pediatric Dermatology, Hospital for Sick Children, Toronto, Canada
^q St John’s Institute of Dermatology, King’s College London and Guy’s & St Thomas’ NHS Foundation Trust, London, UK
^r Dermatology Centre, Salford Royal Hospital, NIHR Manchester Biomedical Research Centre, University of Manchester, Manchester, UK
^s Clinical Medicine, Trinity College Dublin, Dublin, Ireland
^t Department of Dermatology, Public Health and Epidemiology; Immunity and Infections, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, the Netherlands
^u Unit for Population-Based Dermatology Research, St John’s Institute of Dermatology, King’s College London and Guy’s & St Thomas’ NHS Foundation Trust, London, UK
^v Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany
^w Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA

^∗Corresponding author. Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114.Massachusetts General Hospital55 Fruit StreetBostonMA02114

conectar o crear una cuenta

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Resumen

During the COVID-19 pandemic, rapid, real-world evidence is essential for the development of knowledge and subsequent public health response. In dermatology, provider-facing and patient-facing registries focused on COVID-19 have been important sources of research and new information aimed at guiding optimal patient care. The 7 dermatology registries included in this update now include more than 8000 case reports sourced from physicians and patients from countries all over the world.

El texto completo de este artículo está disponible en PDF.

Keywords : COVID-19, SARS-CoV-2, Dermatology, Global health, Registry, Psoriasis, Hidradenitis suppurativa, Atopic dermatitis